Idera Pharmaceuticals CEO Vincent Milano's 2020 pay rises 1% to $1.3M
Idera Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: April 28, 2021
Idera Pharmaceuticals reported fiscal year 2020 executive compensation information on April 28, 2021.
In 2020, five executives at Idera Pharmaceuticals received on average a compensation package of $877K, a 2% increase compared to previous year.
Average pay of disclosed executives at Idera Pharmaceuticals
Vincent J. Milano, Chief Executive Officer, received $1.3M in total, which increased by 1% compared to 2019. 57% of Milano's compensation, or $765K, was in stock awards. Milano also received $285K in non-equity incentive plan, $235K in option awards, $25K in salary, as well as $38K in other compensation.
For fiscal year 2020, the median employee pay was $304,212 at Idera Pharmaceuticals. Therefore, the ratio of Vincent J. Milano's pay to the median employee pay was 4 to one.
R. Clayton Fletcher, Senior Vice President, Business Development and Strategy, received a compensation package of $893K, which increased by 12% compared to previous year. 45% of the compensation package, or $400K, was in salary.
John J. Kirby, Chief Financial Officer, earned $765K in 2020, a 26% increase compared to previous year.
Elizabeth Tarka, Chief Medical Officer, received $698K in 2020.
Bryant D. Lim, General Counsel, earned $681K in 2020, a 7% decrease compared to previous year.
Related executives
Vincent Milano
Idera Pharmaceuticals
Chief Executive Officer
John Kirby
Idera Pharmaceuticals
Chief Financial Officer
Bryant Lim
Idera Pharmaceuticals
General Counsel
Elizabeth Tarka
Idera Pharmaceuticals
Chief Medical Officer
R Fletcher
Idera Pharmaceuticals
Senior Vice President, Business Development and Strategy
You may also like
Source: SEC filing on April 28, 2021.